Akari Therapeutics, Plc Shares Outstanding (Cover Page)
Akari Therapeutics, Plc (AKTX) had Shares Outstanding (Cover Page) of 155.76 billion shares as of 2026-08-13, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-13: Entity Common Stock, Shares Outstanding 155.76B shares.
- 2026-05-19: Entity Common Stock, Shares Outstanding 91.57B shares.
- 2026-03-01: Entity Common Stock, Shares Outstanding 91.57B shares.
- 2025-11-13: Entity Common Stock, Shares Outstanding 71.48B shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 155.76B shares 10-Q · filed 2026-08-13 |
| 2026-05-19 | 91.57B shares 10-Q · filed 2026-05-19 |
| 2026-03-01 | 91.57B shares 10-K · filed 2026-03-30 |
| 2025-11-13 | 71.48B shares 10-Q · filed 2025-11-13 |
| 2025-08-13 | 65.23B shares 10-Q · filed 2025-08-13 |
| 2025-05-09 | 64.35B shares 10-Q · filed 2025-05-14 |
| 2025-03-31 | 57.75B shares 10-K · filed 2025-04-15 |
| 2024-11-15 | 49.52B shares 10-Q · filed 2024-11-19 |
| 2024-08-09 | 23.91B shares 10-Q · filed 2024-08-19 |
| 2024-05-10 | 15.85B shares 10-Q · filed 2024-05-15 |
| 2024-03-29 | 15.85B shares 10-K · filed 2024-03-29 |
| 2022-12-31 | 7.44B shares 20-F · filed 2023-05-01 |
| 2021-12-31 | 4.76B shares 20-F · filed 2022-05-16 |
| 2020-12-31 | 3.85B shares 20-F · filed 2021-04-21 |
| 2019-12-31 | 2.25B shares 20-F · filed 2020-03-31 |
| 2018-12-31 | 1.58B shares 20-F · filed 2019-04-23 |
| 2018-06-30 | 1.53B shares 6-K · filed 2018-09-27 |
| 2017-12-31 | 1.53B shares 20-F · filed 2018-07-18 |
| 2017-06-30 | 1.18B shares 6-K · filed 2017-08-10 |
| 2016-12-31 | 1.18B shares 20-F · filed 2017-03-31 |
| 2016-06-30 | 0.00 shares 6-K · filed 2017-04-14 |
| 2016-05-12 | 1.18B shares 10-Q · filed 2016-05-12 |
| 2016-03-23 | 1.18B shares 10-K · filed 2016-03-23 |
| 2015-11-16 | 1.18B shares 10-Q · filed 2015-11-23 |
| 2015-08-12 | 55.64M shares 10-Q · filed 2015-08-12 |
| 2015-05-12 | 55.64M shares 10-Q · filed 2015-05-12 |
| 2015-02-11 | 55.64M shares 10-K · filed 2015-02-11 |
| 2013-12-31 | 40.23M shares 20-F · filed 2014-03-24 |
| 2012-12-31 | 13.37M shares 20-F/A · filed 2013-04-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |